LinkedIn · Jan 2026
Co-founder Danielle J. Yoesep announced the acquisition and thanked the founding team and core staff.
Connecting All Ages with Speech Language Pathologists
Public company, workplace, funding, and market signals
Updated Aug 16, 2026
Verse Therapy (YC W24) appears to be a small, early-stage home health care company associated with the brand/alias Hona AI, focused on AI-enabled therapy support for home health care use cases. Public evidence is limited, so some operating details could not be verified from primary sources.
Primary product
AI-enabled therapy support software/service for home health care (Hona AI / Verse Therapy)
Team size
1-10 employees
Industry
Home Health Care Services
Sub-industry
AI-enabled healthcare / therapy support software
Business model
Stage
Seed
Total raised
$3.1M
Latest round
Seed · May 2024
Latest amount
$3M
Mar 2024
Leadership
Yena Kim
Founder of Hesed Speech and Language, PLLC & Partner
Danielle J. Yoesep
Founder & COO
Differentiators
Technology
Competitors
LinkedIn · Jan 2026
Co-founder Danielle J. Yoesep announced the acquisition and thanked the founding team and core staff.
LinkedIn · Jan 2026
Verse co-founder Adam Steinle announced that Verse Therapy was acquired by Beaming Health.
PitchBook
PitchBook listed Verse Therapy as founded in 2024 and acquired by Beaming Health on 2025-12-12, with investors including 1984 Ventures, Orange Collective, Ripple Impact Investments, Valia Ventures, and Y Combinator.
Y Combinator
Y Combinator described Verse Therapy as a company helping speech-language pathologists launch and grow independent practices through an AI-enabled back office and noted it was live in 10 states with 35+ therapists.
Indexed.vc
Indexed.vc summarized Verse Therapy as a San Francisco-based digital health company founded in 2024 with reported seed funding and investors including 1984 Ventures, Orange Collective, Valia Ventures, and Y Combinator Continuity Fund.
6 jobs at Verse Therapy